A preeclampsia risk prediction model based on maternal characteristics and serum markers in twin pregnancy

References

• Ree PH, Hahn WB, Chang SW, et al. Early detection of preeclampsia using inhibin A and other second-trimester serum markers. Fetal Diagn Ther. 2011;29(4):280–286.
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang H, Liu F, et al. Ameliorative effects of aspirin against lipopolysaccharide-induced preeclampsia-like symptoms in rats by inhibiting the pro-inflammatory pathway. Can J Physiol Pharmacol. 2018;96(11):1084–1091.
   PubMed Web of Science ®Google Scholar
• Hoffman BL, Horsager R, Roberts S. Williams obstetrics study guide. New York: McGraw-Hill Professional Publishing; 2015.
   Google Scholar
• Timofeeva AV, Gusar VA, Kan NE, et al. Identification of potential early biomarkers of preeclampsia. Placenta. 2018;61:61–71.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH. A model for a new pyramid of prenatal care based on the 11 to 13 weeks’ assessment. Prenat Diagn. 2011;31(1):3–6.
   PubMed Web of Science ®Google Scholar
• Svirsky R, Maymon R, Melcer Y, et al. First and second trimester maternal serum inhibin A levels in twins with pre-eclampsia. Prenat Diagn. 2016;36(11):1071–1074.
   PubMed Web of Science ®Google Scholar
• Fox NS, Roman AS, Saltzman DH, et al. Risk factors for preeclampsia in twin pregnancies. Amer J Perinatol. 2014;31(2):163–166.
   PubMed Web of Science ®Google Scholar
• The American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 743 Summary: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):254–256.
   PubMedGoogle Scholar
• Milunsky A, Wands J, Brambati B, et al. First-trimester maternal serum alpha fetoprotein screening for chromosome defects. Am J Obstet Gynecol. 1988;159(5):1209–1213.
   PubMed Web of Science ®Google Scholar
• Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn. 1987;7(9):623–630.
   PubMed Web of Science ®Google Scholar
• Dugoff L. Society for Maternal-Fetal Medicine. First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes. Obstet Gynecol. 2010;115(5):1052–1061.
   PubMed Web of Science ®Google Scholar
• Gagnon A, Wilson RD, Audibert F, et al. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can. 2008;30(10):918–932.
   PubMedGoogle Scholar
• Sharma N, Jayashree K, Nadhamuni K. Maternal history and uterine artery wave form in the prediction of early-onset and late-onset preeclampsia: a cohort study. IJRM. 2018;16(2):109–114.
   Google Scholar
• Rădulescu C, Bacârea A, Huțanu A, et al. Placental growth factor, soluble fms-Like tyrosine kinase 1, soluble endoglin, IL-6, and IL-16 as biomarkers in preeclampsia. Mediators Inflamm. 2016;2016:1.
   Web of Science ®Google Scholar
• Dröge L, Herraìz I, Zeisler H, et al. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies. Ultrasound Obstet Gynecol. 2015;45(3):286–293.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Hauth J, Caritis S, et al. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 2000;182(4):938–942.
   PubMed Web of Science ®Google Scholar
• Robinson HP, Fleming JE. A critical evaluation of sonar “crown-rump length” measurements. BJOG. 1975;82(9):702–710.
   Web of Science ®Google Scholar
• Lindheimer MD, Taler SJ, Cunningham FG, et al. ASH position paper: hypertension in pregnancy. J Clin Hypertens (Greenwich). 2009;11(4):214–225.
   PubMed Web of Science ®Google Scholar
• Publications Committee, Society for Maternal-Fetal Medicine, Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks’ gestation. Am J Obstet Gynecol. 2011;205(3):191–198.
   PubMed Web of Science ®Google Scholar
• Saleh L, Tahitu SIM, Danser AHJ, et al. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies. Preg Hypertens. 2018;14:222–227.
   Web of Science ®Google Scholar
• Svirsky R, Meiri H, Herzog A, et al. First trimester maternal serum placental protein 13 levels in singleton vs. twin pregnancies with and without severe pre-eclampsia. J Perinat Med. 2013;41(5):561–566.
   PubMed Web of Science ®Google Scholar
• Park HJ, Kim SH, Jung YW, et al. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy. BMC Preg Childbirth. 2014;14:35.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Koch MA, Freire S, et al. Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia? Am J Obstet Gynecol. 2008;199(3):268.e1–268.e9.
   Web of Science ®Google Scholar
• Aquilina J, Maplethorpe R, Ellis P, et al. Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia. Placenta. 2000;21(5-6):487–492.
   PubMed Web of Science ®Google Scholar
• Kirkegaard I, Uldbjerg N, Oxvig C. Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: an overview. Acta Obstet Gynecol Scand. 2010;89(9):1118–1125.
   PubMed Web of Science ®Google Scholar
• Bilano VL, Ota E, Ganchimeg T, et al. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLoS One. 2014;9(3):e91198.
   PubMed Web of Science ®Google Scholar
• Lee CJ, Hsieh TT, Chiu TH, et al. Risk factors for pre-eclampsia in an Asian population. Int J Gynecol Obstet. 2000;70(3):327–333.
   PubMed Web of Science ®Google Scholar
• Ohel-Shani I, Daniel-Spiegel E. Turning the pyramid in prenatal care. Harefuah. 2015;154(10):653–656.
   PubMedGoogle Scholar
• Roberge S, Nicolaides KH, Demers S, et al. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol. 2013;41(5):491–499.
   PubMed Web of Science ®Google Scholar
• O’Gorman N, Wright D, Rolnik DL, et al. Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with aspirin for evidence-based preeclampsia prevention (ASPRE). BMJ Open. 2016;6(6):e011801.
   PubMed Web of Science ®Google Scholar
• Almeida ST, Katz L, Coutinho I, et al. Validation of fullPIERS model for prediction of adverse outcomes among women with severe pre-eclampsia. Int J Gynecol Obstet. 2017;138(2):142–147.
   PubMed Web of Science ®Google Scholar